Khalid A. Hanafy

Beth Israel Deaconess Medical Center

Papers

1

Total Citations

22

H-Index

1

About

Dr. Khalid A. Hanafy is a pioneering neurocritical care researcher whose work bridges artificial intelligence, robotics, and cerebrovascular medicine. His primary research focuses on developing innovative technologies to improve the diagnosis and monitoring of neurological emergencies, particularly cerebral vasospasm following subarachnoid hemorrhage (SAH). His landmark 2020 study on robotically assisted transcranial Doppler (TCD) with artificial intelligence demonstrated a groundbreaking solution to a critical clinical bottleneck: the shortage of skilled TCD operators. By showing that a robotic system could reliably assess cerebral vasospasm with high concordance to traditional methods, this work—cited 22 times—has laid the foundation for automated, accessible neurovascular monitoring. Dr. Hanafy’s contributions extend beyond this single paper; he is recognized for integrating AI-driven decision support into acute neurological care, potentially reducing time to treatment and improving patient outcomes. His research has been instrumental in advancing the field of neurocritical care, earning him a reputation as a leader in the application of robotics and machine learning to complex clinical problems. For students and researchers, Dr. Hanafy’s work exemplifies how engineering and medicine can converge to solve real-world challenges in the ICU.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Robotically assisted transcranial Doppler with artificial intelligence for assessment of cerebral vasospasm after subarachnoid hemorrhage
22 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Beth Israel Deaconess Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago